AMYRIAD THERAPEUTICS
DEAD

Serial Number

97107538

Owner

AmyriAD Therapeutics B.V.

Attorney

John Paul Oleksiuk

Filing Date

Nov 3, 2021

Add to watchlist:

No watchlists yet
View on USPTO

AMYRIAD THERAPEUTICS Trademark

Serial Number: 97107538

AMYRIAD THERAPEUTICS is a trademark filed by AmyriAD Therapeutics B.V. on November 3, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

AmyriAD Therapeutics B.V. (3 trademarks)

444 S. Flower Street, Suite 1300

Entity Type: 99

Trademark Details

Filing Date

November 3, 2021

Registration Date

Not Registered

Goods & Services

Pharmaceuticals, namely, pharmaceutical preparations to treat neurodegenerative diseases; pharmaceuticals, namely, pharmaceutical preparations to attenuate the accumulation of dysfunctional proteins

Pharmaceutical research and development services; scientific research in the nature of conducting clinical trials in the field of neurodegenerative diseases; scientific research in the nature of conducting clinical trials in the field of dysfunctional protein accumulation; research and development in the field of biotechnology; research and development in the field of biochemistry; information, advisory and consultancy services in relation to all of the foregoing

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 2, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 2, 2026 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Sep 9, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Sep 9, 2025 XELR
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jun 11, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jun 11, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Jun 11, 2025 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 8, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 6, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 6, 2024 GNSL
SUSPENSION LETTER WRITTEN
Dec 6, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 15, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 15, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 15, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 14, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 14, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 16, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 16, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 16, 2024 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 15, 2024 RCCK
ASSIGNED TO EXAMINER
Jan 12, 2024 DOCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 13, 2023 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 27, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 27, 2023 GNSL
SUSPENSION LETTER WRITTEN
Feb 27, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 18, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 17, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 17, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 19, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 19, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 19, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 12, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 15, 2021 NWOS
NEW APPLICATION ENTERED
Nov 6, 2021 NWAP